Toronto, Ontario / May 17, 2018 – Cannvas MedTech Inc. (“Cannvas” or the “Company”), a leading business technology company within the cannabis space, is pleased to announce its lead sponsorship role at the upcoming Medical Cannabis Week in Toronto. This inaugural event brings together the thought leaders in the Canadian medical cannabis sector and is presented by Business of Cannabis in partnership with Cannvas MedTech, WeedMD, Ample Organics, TechTO, HealthTO, SheCann, Blakes, Cassels & Graydon LLP, RNMKR PR, Salesforce, Emblem and other leading industry partners.

“As a new technology company developing innovative solutions to empower medical cannabis patients to take control of their healthcare experience, we jumped at the opportunity to be part of Medical Cannabis Week,” said Shawn Moniz, chief executive officer of Cannvas MedTech. “I look forward to introducing Cannvas MedTech and our story to an impressive lineup of Canadian industry peers who are leading the world in medical cannabis.”

With more than 260,000 Canadians having legal, medical access to cannabis, Medical Cannabis Week is a dedicated opportunity to engage in conversation about an alternative medicine touching a growing number of Canadians. Founded by Business of Cannabis and observed by a series of founding partners, Medical Cannabis Week seeks to expand dialogue and examine the potential for medical cannabis to deliver significant and positive patient benefits.

The agenda includes: the Technology and Innovation Showcase in partnership with TechTO and HealthTO and sponsored by Cannvas MedTech; the State of Patients featuring data from SheCann and Strainprint; a 360º roundtable discussion on medical cannabis policy convened by Blakes, and much more.

About Medical Cannabis Week

Medical Cannabis Week is a dedicated opportunity to engage in conversation about an alternative medicine touching a growing number of Canadians. Founded by Business of Cannabis and observed by a series of founding partners, Medical Cannabis Week will expand the dialogue and examine the potential for medical cannabis to deliver significant and positive patient benefits. The events will be hosted at locations across Toronto on May 22, 23 and 24 and all materials will be available digitally. To request an invitation or to learn more about the events, please visit medicalcannabisweek.com.

About Business of Cannabis

Business of Cannabis is the authoritative platform for news, analysis and insights into the Business of Canada’s cannabis sector. We believe that expert information empowers professionals to best leverage opportunities and navigate obstacles. We produce original multiplatform content and cross sector coverage to serve those working in and alongside the industry. Find out more: businessofcannabis.ca.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:

www.cannvasmedtech.com

ir@cannvasmedtech.com

1-800-489-0116

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Welcome!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!